I spent all weekend going to and fro between IQE:IQE and OPTI:Optibiotix for my £790 SIPP windfall.
Where to invest my tax rebate and CAML:Central Asia Metals dividend?
Although I really want to increase my IQE:IQE holding, I convinced myself it was a bit toppy, and at around 144p could easily drop to the mid 120's.
Whereas OPTI:Optibiotix at 74p was clearly still under-valued for what's about to happen, and every extra share purchased is another contribution towards increasing the number of free Sweetbiotix shares when that's spun off - and that's where the big, big gains are going to be (in my humble opinion).
So it was with great joy that I purchased 1,059 shares this morning for a bargain 73.33p costing £788.51.
I should have waited!!
Why do I always get the timing so wrong?
OPTI:Optibiotix dropped to an offer price of 71p by the end of the day, whereas IQE:IQE climbed from offer price of 144p to a bid price of 151.5p which would have left me up on the day.
So despite IQE:IQE making me loads of money today and going past 400% up in my ISA, OPTI:Optibiotix dropped 3p and with my extended holding each penny cost £450, leaving the combined portfolios £823 down on the day.
I don't regret buying more OPTI:Optibiotix as I'm still utterly convinced that long-term revenues are highly likely when these products catch on and distribution deals are announced in UK and USA. The low cost model and tiny number of shares in circulation mean that when demand appears and the traders stop trading, shares are going to be very hard to get.
So I'm feeling peeved at yet another badly timed purchase, but I have no regrets.
Monday 30 October 2017
Friday 27 October 2017
Week 116 Review - Great gains despite some significant poor performers
This was a very good week, but the gains were down to a few key shares doing well. Some of my other key shares did quite badly but the drop was well hidden. The combined portfolios ended up £1,847 higher than last week, with an additional £784 cash from dividends and tax rebates taking the total value to £78,370. There's a very healthy £7,292 buffer between cost and value.
The worst performing share was CAML:Central Asia Metals which dropped 8% but made up for it with a cracking £174 dividend. I don't know why this is dropping, as the price of copper is still flying high. Maybe it's the risk of their recent acquisition?
MTFB:Motif Bio had a bad week, dropping 6%, but they are still up by 34% on purchase price after very little time.
My concerns about TRX:Tissue Regenix deepen as the shares drop yet again by 5% and are now losing 59% which amounts to £1,060 and makes this my new Nemesis Share. KIBO:Kibo Mining had a 20% rally today after dropping down during the week and holding the wooden spoon until today.
AMYT:Amryt Pharma is sliding a little every week, and although the drop was only 4%, that means a lot of money lost and these are only 3% up now so will go to loss if the downturn continues. I'd be tempted to top up at that level, but this is already 9% of my portfolio and I think that's enough.
The best news was OPTI:Optibiotix climbing 3p which is 5% and putting my holdings in all three accounts (Share, ISA and SIPP) into profit. This is now making a combined paper profit of £1,835 so has gone from Nemesis Share to my 3rd best share behind only CAML:Central Asia Metals (£1,872 potential profit) and Star Share IQE:IQE (£7,646 potential profit).
RED:RedT Energy is on a roll, climbing another 5% to go 7% (£74) up.
IQE:IQE climbed 8% in my SIPP and 35% in my ISA so misses out on Share of the Week because the ISA account is kinda cheating as the purchase price was so low.
Share of the Week goes to TLOU:Tlou Energy for the 2nd week in a row, climbing 23% and going 21% up with £285 potential profit. This is just the start - once they get picked to build the new power plant we should see a big re-rate.
Nearly back up to the all-time high, and momentum in the right direction.
The ISA and share accounts look like this
The £10.34 dividend came from CMCL:Caledonia Mining which pays a nice quarterly amount. Profits were up nicely, mainly thanks to IQE:IQE, RED:RedT Energy and TLOU:Tlou Energy, with OPTI:Optibiotix contributing once it switched from loss to profit in the ISA. Losses reduced too, so overall value is up by £1,453.
Look how long these accounts have been in the black now - such a long wait but we're finally there.
The SIPP looks like this after week 100.
A fantastic whacking great dividend of £174.07 arrived on the same day as a £600 tax rebate from when I added £2,400 in September to buy IQE:IQE. I'm sure it used to take 3 months for the tax to come through, but the rules must have changed. The timing is great, as I can put it together with the dividend and buy something next week.
Potential profits rose by £494 but the TRX:Tissue Regenix loss meant the total value only went up by £408. With only 4 weeks of year 2 left and a current performance of 30% profit, it's been a very successful year for the SIPP whatever happens over the next few weeks. Let's hope that's not tempting fate!
Go graph go!
OK - time to take a deep breath and go through the torment of the trading account after week 66
I couldn't be bothered saying anything about this.
Nah - not worth the effort
So next week sees the launch of the iPhone X and all the hype surrounding it. What will that mean for IQE:IQE? I have a decision to make over my £774 SIPP money. Part of me wants to use it to extend my IQE:IQE holding, but is the current price a bit toppy considering all the short interest? You could argue that the iPhone X launch may cause the shorters to close and the price could rocket, so maybe a Monday purchase would be a good idea?
The other option is to reward CAML:Central Asia Metals for the dividend by re-investing it there. I do really like this company and the price did drop for no reason this week so the timing could be good.
The other option is to get yet more OPTI:Optibiotix, which is very tempting but would increase my price average in the SIPP that I took so much trouble to bring down to 64.6p. I never thought I would say this - but 74p is a bit expensive!
I had a look at my previous holdings, but there's nothing standing out that could compete with the three mentioned above, unless I take advantage of the dip in gold to buy PAF:Pan African Resources. They will be paying a 0.48697p dividend in December and I've benefitted from that over the last few years. I'd get around 5,900 shares for £774 which would give me... hmmm... £28. Nah - I don't think I'll bother this year.
I think IQE:IQE is the best bet as the prospects over the next few years are amazing and the iPhone launch could very well see an instant rise if the shorters all bail. Let's see what next week brings...
The worst performing share was CAML:Central Asia Metals which dropped 8% but made up for it with a cracking £174 dividend. I don't know why this is dropping, as the price of copper is still flying high. Maybe it's the risk of their recent acquisition?
MTFB:Motif Bio had a bad week, dropping 6%, but they are still up by 34% on purchase price after very little time.
My concerns about TRX:Tissue Regenix deepen as the shares drop yet again by 5% and are now losing 59% which amounts to £1,060 and makes this my new Nemesis Share. KIBO:Kibo Mining had a 20% rally today after dropping down during the week and holding the wooden spoon until today.
AMYT:Amryt Pharma is sliding a little every week, and although the drop was only 4%, that means a lot of money lost and these are only 3% up now so will go to loss if the downturn continues. I'd be tempted to top up at that level, but this is already 9% of my portfolio and I think that's enough.
The best news was OPTI:Optibiotix climbing 3p which is 5% and putting my holdings in all three accounts (Share, ISA and SIPP) into profit. This is now making a combined paper profit of £1,835 so has gone from Nemesis Share to my 3rd best share behind only CAML:Central Asia Metals (£1,872 potential profit) and Star Share IQE:IQE (£7,646 potential profit).
RED:RedT Energy is on a roll, climbing another 5% to go 7% (£74) up.
IQE:IQE climbed 8% in my SIPP and 35% in my ISA so misses out on Share of the Week because the ISA account is kinda cheating as the purchase price was so low.
Share of the Week goes to TLOU:Tlou Energy for the 2nd week in a row, climbing 23% and going 21% up with £285 potential profit. This is just the start - once they get picked to build the new power plant we should see a big re-rate.
Nearly back up to the all-time high, and momentum in the right direction.
The ISA and share accounts look like this
| Weekly Change | |||
| Cash | £49.93 | +£10.34 | |
| Portfolio cost | £44,426.84 | +£0 | |
| Portfolio sell value (bid price - commission) | £49,161.77 | (+10.7%) | +£1,453.19 |
| Potential profits | £9,545.25 | +£1,065.83 | |
| Yr 3 Dividends | £10.34 | +£10.34 | |
| Yr 3 Profit from sales | £585.38 | +£0 | |
| Yr 3 Average monthly cash profit | £196.15 | (5.3%) | -£13.76 |
| Total Dividends | £1,189.39 | +£10.34 | |
| Total Profit from sales | £7,297.85 | +£0 | |
| Average monthly cash profit | £312.84 | (8.4%) | -£2.33 |
| (Sold stocks profit + Dividends - Fees / Months) |
The £10.34 dividend came from CMCL:Caledonia Mining which pays a nice quarterly amount. Profits were up nicely, mainly thanks to IQE:IQE, RED:RedT Energy and TLOU:Tlou Energy, with OPTI:Optibiotix contributing once it switched from loss to profit in the ISA. Losses reduced too, so overall value is up by £1,453.
Look how long these accounts have been in the black now - such a long wait but we're finally there.
The SIPP looks like this after week 100.
| Weekly Change | |||
| Cash | £818.70 | +£774.07 | |
| Portfolio cost | £25,218.51 | +£0 | |
| Portfolio sell value (bid price - commission) | £27,911.22 | (10.7%) | +£408.49 |
| Potential profits | £4,069.87 | +£494.80 | |
| Yr 2 Dividends | £502.91 | +£174.07 | |
| Yr 2 Profit from sales | £6,575.33 | +£0 | |
| Yr 2 Average monthly cash profit | £631.23 | (30%) | +£2.62 |
| Total Dividends | £916.10 | +£174.07 | |
| Total Profit from sales | £8,925.19 | +£0 | |
| Average monthly cash profit | £420.52 | (20%) | +£3.37 |
| (Sold stocks profit + Dividends - Fees / Months) |
A fantastic whacking great dividend of £174.07 arrived on the same day as a £600 tax rebate from when I added £2,400 in September to buy IQE:IQE. I'm sure it used to take 3 months for the tax to come through, but the rules must have changed. The timing is great, as I can put it together with the dividend and buy something next week.
Potential profits rose by £494 but the TRX:Tissue Regenix loss meant the total value only went up by £408. With only 4 weeks of year 2 left and a current performance of 30% profit, it's been a very successful year for the SIPP whatever happens over the next few weeks. Let's hope that's not tempting fate!
Go graph go!
OK - time to take a deep breath and go through the torment of the trading account after week 66
| Weekly Change | |||
| Cash | £79.63 | +£0 | |
| Portfolio cost | £486.05 | +£0 | |
| Portfolio sell value (bid price - commission) | £349.45 | (-28.1%) | -£13.90 |
| Potential profits | £0 | +£0 | |
| Dividends | £1.15 | +£0 | |
| Profit from sales | -£22.85 | +£0 | |
| Average monthly cash profit | -£1.42 | (-3.5%) | +£0.03 |
| (Sold stocks profit + Dividends - Fees / Months) |
I couldn't be bothered saying anything about this.
Nah - not worth the effort
So next week sees the launch of the iPhone X and all the hype surrounding it. What will that mean for IQE:IQE? I have a decision to make over my £774 SIPP money. Part of me wants to use it to extend my IQE:IQE holding, but is the current price a bit toppy considering all the short interest? You could argue that the iPhone X launch may cause the shorters to close and the price could rocket, so maybe a Monday purchase would be a good idea?
The other option is to reward CAML:Central Asia Metals for the dividend by re-investing it there. I do really like this company and the price did drop for no reason this week so the timing could be good.
The other option is to get yet more OPTI:Optibiotix, which is very tempting but would increase my price average in the SIPP that I took so much trouble to bring down to 64.6p. I never thought I would say this - but 74p is a bit expensive!
I had a look at my previous holdings, but there's nothing standing out that could compete with the three mentioned above, unless I take advantage of the dip in gold to buy PAF:Pan African Resources. They will be paying a 0.48697p dividend in December and I've benefitted from that over the last few years. I'd get around 5,900 shares for £774 which would give me... hmmm... £28. Nah - I don't think I'll bother this year.
I think IQE:IQE is the best bet as the prospects over the next few years are amazing and the iPhone launch could very well see an instant rise if the shorters all bail. Let's see what next week brings...
Saturday 21 October 2017
Week 115 Review - Mainly down but Optibiotix saves the day
Week 115 has been pretty quiet. No major volatility, but lots of small falls across the board. Thankfully OPTI:Optibiotix gained 2p which saved the day and resulted in the combined portfolios finishing £517 better off than last week. The buffer between cost and value is now £5,444 and overall value £75,738.
Worst performer was KIBO:Kibo Mining, dropping 9% and back below 5p. This is 32% down since purchase but I still believe it will re-rate significantly once the final agreements for the power station come through. I would top up, but it's still quite high risk and I've invested enough already.
I'm still worried about TRX:Tissue Regenix which fell another 6% and is now down by 54%. I had such high hopes, but they seem to be struggling to earn revenue despite having a fantastic product. The CEO has stepped down so maybe there's an opportunity for someone with more of a head for commercialisation to take over. Normally I'd be topping up after a dip of this magnitude, but I'm not convinced enough to take the risk.
Better performance for SBTX:SkinBioTherapeutics this week, climbing 6% but still losing 28% on purchase price. The only reason I'm not increasing my holding at this price is the promise of free shares from OPTI:Optibiotix which will satisfy my desire to hold more. OPTI:Optibiotix themselves climbed 2p and ensured the portfolios stayed in the black for the week. When will it finally break out of this 2-year trading range?
Share of the Week is TLOU:Tlou Energy which climbed 11% but is still 2% away from break-even. I'm expecting this to double in the next 6 months and would buy more if I had the cash.
Looks like we've been pretty much level for almost a month now. Compared to the volatility prior to that, it's been a very quiet time.
The ISA and share accounts look like this
A small increase in value mainly from reduced losses, as potential profits were savaged by drops in AMYT:Amryt Pharma, IQE:IQE, MTFB:Motif Bio and RED:RedT Energy. These are a significant proportion of my best shares so it was a tad upsetting they all had a bad week.
Very similar to the overall graph yet again, with a nice consolidation in the black.
The SIPP looks like this after week 99
Much better performance this week largely thanks to increasing profits for CAML:Central Asia Metals, OPTI:Optibiotix and LGEN:Legal & General. Those rises were offset by deepening losses in ARL:Atlantis Resources and TRX:Tissue Regenix which caused the value to increase by less than the increase in paper profits.
Just a little bit more of an upward trend on this chart. I'd be happy if it stays like that for a few months.
The trading account looks like this after week 65
Nothing to say - just want to sell and start again from scratch!
So frustrating - if I ever do this properly I'll look back on this period and giggle hysterically
Last week I predicted this would be a dull one and I think I was right. The only excitement was IQE:IQE revealing they had "discovered" £4.2m of unpaid taxes from a company they bought out a few years back. I feared the worst, but the share price was hardly dented, showing that people are looking past a few million to the massive profits that are not too far ahead.
There was some further excitement after hours when AFPO:African Potash finally came out of hiding, announced final results and gave up on their potential purchase of another company. The suspension on the shares will be lifted on Monday morning. Given their annual report revealed net income of $9,000 from trading for the whole year and an operating loss of $1.9m, I doubt there's going to be a queue of people waiting to buy! My only hope is they'll make something from farming out Lac Dinga else I'll never see my money again.
Next week will see a few dividends appear. CMCL:Caledonia Mining are paying out around £10 on Friday as the quarterly dividend, but it may not hit my account in time for the weekend update. CAML:Central Asia Metals are paying out around £174 as the interim dividend, also on Friday so again it may not arrive in time for the review.
No results expected next week, so once again there's nothing to prepare for other than surprises...
Worst performer was KIBO:Kibo Mining, dropping 9% and back below 5p. This is 32% down since purchase but I still believe it will re-rate significantly once the final agreements for the power station come through. I would top up, but it's still quite high risk and I've invested enough already.
I'm still worried about TRX:Tissue Regenix which fell another 6% and is now down by 54%. I had such high hopes, but they seem to be struggling to earn revenue despite having a fantastic product. The CEO has stepped down so maybe there's an opportunity for someone with more of a head for commercialisation to take over. Normally I'd be topping up after a dip of this magnitude, but I'm not convinced enough to take the risk.
Better performance for SBTX:SkinBioTherapeutics this week, climbing 6% but still losing 28% on purchase price. The only reason I'm not increasing my holding at this price is the promise of free shares from OPTI:Optibiotix which will satisfy my desire to hold more. OPTI:Optibiotix themselves climbed 2p and ensured the portfolios stayed in the black for the week. When will it finally break out of this 2-year trading range?
Share of the Week is TLOU:Tlou Energy which climbed 11% but is still 2% away from break-even. I'm expecting this to double in the next 6 months and would buy more if I had the cash.
Looks like we've been pretty much level for almost a month now. Compared to the volatility prior to that, it's been a very quiet time.
The ISA and share accounts look like this
| Weekly Change | |||
| Cash | £39.59 | +£0 | |
| Portfolio cost | £44,426.84 | +£0 | |
| Portfolio sell value (bid price - commission) | £47,708.58 | (+7.4%) | +£112.67 |
| Potential profits | £8,479.42 | -£345.27 | |
| Yr 3 Dividends | £0 | +£0 | |
| Yr 3 Profit from sales | £585.38 | +£0 | |
| Yr 3 Average monthly cash profit | £209.91 | (5.7%) | -£20.99 |
| Total Dividends | £1,179.05 | +£0 | |
| Total Profit from sales | £7,297.85 | +£0 | |
| Average monthly cash profit | £315.17 | (8.5%) | -£2.76 |
| (Sold stocks profit + Dividends - Fees / Months) |
A small increase in value mainly from reduced losses, as potential profits were savaged by drops in AMYT:Amryt Pharma, IQE:IQE, MTFB:Motif Bio and RED:RedT Energy. These are a significant proportion of my best shares so it was a tad upsetting they all had a bad week.
Very similar to the overall graph yet again, with a nice consolidation in the black.
The SIPP looks like this after week 99
| Weekly Change | |||
| Cash | £44.63 | +£0 | |
| Portfolio cost | £25,218.51 | +£0 | |
| Portfolio sell value (bid price - commission) | £27,502.73 | (9.1%) | +£407.55 |
| Potential profits | £3,575.07 | +£514.25 | |
| Yr 2 Dividends | £328.84 | +£0 | |
| Yr 2 Profit from sales | £6,575.33 | +£0 | |
| Yr 2 Average monthly cash profit | £628.61 | (29.9%) | -£13.66 |
| Total Dividends | £708.15 | +£0 | |
| Total Profit from sales | £8,925.19 | +£0 | |
| Average monthly cash profit | £417.15 | (19.8%) | -£4.26 |
| (Sold stocks profit + Dividends - Fees / Months) |
Much better performance this week largely thanks to increasing profits for CAML:Central Asia Metals, OPTI:Optibiotix and LGEN:Legal & General. Those rises were offset by deepening losses in ARL:Atlantis Resources and TRX:Tissue Regenix which caused the value to increase by less than the increase in paper profits.
Just a little bit more of an upward trend on this chart. I'd be happy if it stays like that for a few months.
The trading account looks like this after week 65
| Weekly Change | |||
| Cash | £79.63 | +£0 | |
| Portfolio cost | £486.05 | +£0 | |
| Portfolio sell value (bid price - commission) | £363.35 | (-25.2%) | -£2.78 |
| Potential profits | £0 | +£0 | |
| Dividends | £1.15 | +£0 | |
| Profit from sales | -£22.85 | +£0 | |
| Average monthly cash profit | -£1.45 | (-3.6%) | +£0.02 |
| (Sold stocks profit + Dividends - Fees / Months) |
Nothing to say - just want to sell and start again from scratch!
So frustrating - if I ever do this properly I'll look back on this period and giggle hysterically
Last week I predicted this would be a dull one and I think I was right. The only excitement was IQE:IQE revealing they had "discovered" £4.2m of unpaid taxes from a company they bought out a few years back. I feared the worst, but the share price was hardly dented, showing that people are looking past a few million to the massive profits that are not too far ahead.
There was some further excitement after hours when AFPO:African Potash finally came out of hiding, announced final results and gave up on their potential purchase of another company. The suspension on the shares will be lifted on Monday morning. Given their annual report revealed net income of $9,000 from trading for the whole year and an operating loss of $1.9m, I doubt there's going to be a queue of people waiting to buy! My only hope is they'll make something from farming out Lac Dinga else I'll never see my money again.
Next week will see a few dividends appear. CMCL:Caledonia Mining are paying out around £10 on Friday as the quarterly dividend, but it may not hit my account in time for the weekend update. CAML:Central Asia Metals are paying out around £174 as the interim dividend, also on Friday so again it may not arrive in time for the review.
No results expected next week, so once again there's nothing to prepare for other than surprises...
Saturday 14 October 2017
Week 114 Review - Optibiotix drags everything down
It was looking like a fairly flat week, but a 2p drop in OPTI:Optibiotix was enough to end up at a loss. The combined portfolios were down by £422 on last week, but would have been up if OPTI:Optibiotix hadn't lost £878. Overall value is now £75,234 with the buffer between cost and value reduced to £4,927.
Worst performer was last week's Share of the Week MTFB:Motif Bio, falling 10% on profit taking after last week's rise. This is still up by 41% and making £412 paper profit in the very small time I've been a holder, so the drop caused by traders doesn't worry me.
The rest of the story was reasonably positive. CAML:Central Asia Metals had a great end to the week and finished 7% up and back at the same price they were before the placing and announcement of the Lynx Resources takeover. When we get an idea of revenues of the new enlarged company I suspect a significant re-rate, but will we still get an amazing dividend?
ARL:Atlantis Resources had a second good week on the bounce, climbing 9% and sentiment is improving, but they are still down by 35% so it's going to take months of strong sentiment to break even.
Although IQE:IQE only climbed 5% in my SIPP, my ISA holding increased by 23% of the original purchase price taking the gains up to 350% and winning Share of the Week. News this weekend that Apple are fitting the 3D sensors into iPads, and that Samsung are also developing 3D facial recognition may give IQE:IQE a boost next week. One of the shorters closed some of their position during the week which caused a huge spike. When the other positions close this will go bonkers.
I've changed the way I display my portfolio on the right hand side of the blog. I figured using red for shares that were 20% or more down, amber for those 15%-20% down, black for those 0%-15% down and green for those in profit was a bit random. Now all shares are in black, but the % up or down from cost price is now red for negative and green for positive. Same for the weekly movement. As well as being easier on the eye and highlighting which are up or down, it's easier to maintain as the colour HTML code is always present.
A continuation of last week's small loss, but still comfortably in the black.
The ISA and share portfolios look like this
Potential profits were up thanks to RED:RedT Energy and IQE:IQE but losses deepened for OPTI:Optibiotix and JLP:Jubilee Platinum to drag the whole portfolio down. Average profit is down to 8.6% now, so sinking below target 10% but there's nothing I want to sell at the moment. Most of my shares are either in profit but with much further to go, at loss but with the potential for greatness, or at loss and doomed to fester for years. There are certainly no candidates for top-slicing any profit just to get back to my target.
Similar to the overall graph. I'm still happy to be in the black after 2 years in the red.
The SIPP looks like this after week 98
The portfolio value actually went up thanks to good rises for ARL:Atlantis Resources, CAML:Central Asia Metals, IQE:IQE and LGEN:Legal and General so even the drop in OPTI:Optibiotix wasn't enough to stop that. Potential profits did slip slightly as all the OPTI:Optibiotix losses hit that and all of ARL:Atlantis Resources and most of IQE:IQE gains were reduced loss. I won't have to sell anything for over a year to stay above my 10% target thanks to the vast profits I made selling IQE:IQE on their last upward spike.
I'm still waiting for that happy day when OPTI:Optibiotix release the RNS that finally causes the price to surge. It's going to happen, and when it does this graph is going to look great!
Here's the trading account after week 64
This is so rubbish. No change at all and I'm thinking the whole experiment is a write-off. I need to have some rules that I don't hold a share in this account if it loses 10% else it's no different than my other accounts. Granted I may lose the £500 quite quickly, but surely the whole point of a trading account is for short term gains. I'm doing it all wrong, but now it's down by 24% I won't sell until it gets up to 10% loss, then employ my new rule.
Once my new rule kicks in, this graph will look very different.
There's not much due to happen next week. A couple of good dividends are arriving the week after but barring unexpected news, next week could be another dull one.
Worst performer was last week's Share of the Week MTFB:Motif Bio, falling 10% on profit taking after last week's rise. This is still up by 41% and making £412 paper profit in the very small time I've been a holder, so the drop caused by traders doesn't worry me.
The rest of the story was reasonably positive. CAML:Central Asia Metals had a great end to the week and finished 7% up and back at the same price they were before the placing and announcement of the Lynx Resources takeover. When we get an idea of revenues of the new enlarged company I suspect a significant re-rate, but will we still get an amazing dividend?
ARL:Atlantis Resources had a second good week on the bounce, climbing 9% and sentiment is improving, but they are still down by 35% so it's going to take months of strong sentiment to break even.
Although IQE:IQE only climbed 5% in my SIPP, my ISA holding increased by 23% of the original purchase price taking the gains up to 350% and winning Share of the Week. News this weekend that Apple are fitting the 3D sensors into iPads, and that Samsung are also developing 3D facial recognition may give IQE:IQE a boost next week. One of the shorters closed some of their position during the week which caused a huge spike. When the other positions close this will go bonkers.
I've changed the way I display my portfolio on the right hand side of the blog. I figured using red for shares that were 20% or more down, amber for those 15%-20% down, black for those 0%-15% down and green for those in profit was a bit random. Now all shares are in black, but the % up or down from cost price is now red for negative and green for positive. Same for the weekly movement. As well as being easier on the eye and highlighting which are up or down, it's easier to maintain as the colour HTML code is always present.
A continuation of last week's small loss, but still comfortably in the black.
The ISA and share portfolios look like this
| Weekly Change | |||
| Cash | £39.59 | +£0 | |
| Portfolio cost | £44,426.84 | +£0 | |
| Portfolio sell value (bid price - commission) | £47,595.91 | (+7.1%) | -£445.95 |
| Potential profits | £8,824.69 | +£158.89 | |
| Yr 3 Dividends | £0 | +£0 | |
| Yr 3 Profit from sales | £585.38 | +£0 | |
| Yr 3 Average monthly cash profit | £230.90 | (6.2%) | -£25.66 |
| Total Dividends | £1,179.05 | +£0 | |
| Total Profit from sales | £7,297.85 | +£0 | |
| Average monthly cash profit | £317.93 | (8.6%) | -£2.82 |
| (Sold stocks profit + Dividends - Fees / Months) |
Potential profits were up thanks to RED:RedT Energy and IQE:IQE but losses deepened for OPTI:Optibiotix and JLP:Jubilee Platinum to drag the whole portfolio down. Average profit is down to 8.6% now, so sinking below target 10% but there's nothing I want to sell at the moment. Most of my shares are either in profit but with much further to go, at loss but with the potential for greatness, or at loss and doomed to fester for years. There are certainly no candidates for top-slicing any profit just to get back to my target.
Similar to the overall graph. I'm still happy to be in the black after 2 years in the red.
The SIPP looks like this after week 98
| Weekly Change | |||
| Cash | £44.63 | +£0 | |
| Portfolio cost | £25,218.51 | +£0 | |
| Portfolio sell value (bid price - commission) | £27,095.18 | (7.4%) | +£23.35 |
| Potential profits | £3,060.82 | -£21.76 | |
| Yr 2 Dividends | £328.84 | +£0 | |
| Yr 2 Profit from sales | £6,575.33 | +£0 | |
| Yr 2 Average monthly cash profit | £642.27 | (30.6%) | -£14.28 |
| Total Dividends | £708.15 | +£0 | |
| Total Profit from sales | £8,925.19 | +£0 | |
| Average monthly cash profit | £421.41 | (20.1%) | -£4.34 |
| (Sold stocks profit + Dividends - Fees / Months) |
The portfolio value actually went up thanks to good rises for ARL:Atlantis Resources, CAML:Central Asia Metals, IQE:IQE and LGEN:Legal and General so even the drop in OPTI:Optibiotix wasn't enough to stop that. Potential profits did slip slightly as all the OPTI:Optibiotix losses hit that and all of ARL:Atlantis Resources and most of IQE:IQE gains were reduced loss. I won't have to sell anything for over a year to stay above my 10% target thanks to the vast profits I made selling IQE:IQE on their last upward spike.
I'm still waiting for that happy day when OPTI:Optibiotix release the RNS that finally causes the price to surge. It's going to happen, and when it does this graph is going to look great!
Here's the trading account after week 64
| Weekly Change | |||
| Cash | £79.63 | +£0 | |
| Portfolio cost | £486.05 | +£0 | |
| Portfolio sell value (bid price - commission) | £366.13 | (-24.7%) | +£0 |
| Potential profits | £0 | +£0 | |
| Dividends | £1.15 | +£0 | |
| Profit from sales | -£22.85 | +£0 | |
| Average monthly cash profit | -£1.47 | (-3.6%) | +£0.02 |
| (Sold stocks profit + Dividends - Fees / Months) |
This is so rubbish. No change at all and I'm thinking the whole experiment is a write-off. I need to have some rules that I don't hold a share in this account if it loses 10% else it's no different than my other accounts. Granted I may lose the £500 quite quickly, but surely the whole point of a trading account is for short term gains. I'm doing it all wrong, but now it's down by 24% I won't sell until it gets up to 10% loss, then employ my new rule.
Once my new rule kicks in, this graph will look very different.
There's not much due to happen next week. A couple of good dividends are arriving the week after but barring unexpected news, next week could be another dull one.
Sunday 8 October 2017
Week 113 Review - Volatile start but flat end
It's been quite an exciting week for announcements, results and ex dividend dates, but in the end it kind of fizzled out and I ended up losing £515 of the portfolio value, reducing the buffer between profit and loss to £5,349 and the overall value to £75,657.
Worst performer should have done much better on positive results, but SBTX:SkinBioTherapeutics are still quite a way off revenue so that possibly caused the 13% slide this week . These are now down by 34% since that exciting day when I bought them just seconds after the IPO. Bet if I hadn't bought them that day they would have soared! Sweetbiotix will undoubtedly soar the day that launches.
CWR:Ceres Power Holdings had a good week last week, climbing 6%, but this week dropped 9% to wipe out those gains.
WRES:W Resources looked like they might have turned a corner, but it was far too much to hope for as over 250 million shares were issued in yet another placing just after announcing that debt financing would cover remaining costs. I don't trust this company as far as I can throw the tungsten that they are so far failing to produce.
RED:RedT Energy only climbed 4% this week after the last 2 weeks as Share of the Week, but that was enough to take them into profit for the first time in ages.
Good news for ARL:Atlantis Resources which climbed 10% after an article was posted in the Daily Mail. It still leaves them down by 44% though, so a long way to go yet.
IQE:IQE recovered from the recent blip with a rise of 13% in my ISA, but these are going to have double digit movements nearly every week as I'm measuring rises and falls based on % of my purchase price of 29.5p.
Share of the Week was MTFB:Motif Bio with a staggering 36% rise after announcing the success of their phase III trial for Iclaprim. I'm quite surprised it didn't climb even further, although that would result in profit taking and a subsequent drop so maybe it's not a bad thing. Now it's just a case of seeing whether this will be allowed to create value or be bought out by a big boy while it's still cheap.
Seems like a while since the weekly movement was so small it doesn't really register on the graph.
The ISA and share portfolios look like this
Cash dropped due to the monthly ISA fee, potential profits actually grew by £70 but the 3% drop in OPTI:Optibiotix sent that back into loss and contributed most to the drop.
Nothing alarming, just happy to be above the red line.
The SIPP looks like this after week 97
Cash dropped due to monthly fees, profits dropped twice as much as the weekly fall in value thanks to OPTI:Optibiotix and helped by the ARL:Atlantis Resources and IQE:IQE losses improving. CAML:Central Asia Metals survived the dividend ex-date intact and even managed to finish the week 3% up.
Remarkably similar to the previous graph.
The trading account looks like this after week 63
There seemed to be much more positive momentum behind REDS:RedstoneConnect following a possible takeover bid, but that fizzled out when they claimed the approach was lacking in any detail and so wasn't being entertained. There's still no imminent prospect of me getting rid of these and so the account continues to languish in tedium.
Shame the top part of the graph isn't more symmetrical else it might look quite pretty in a few weeks.
Not much news anticipated during next week. REDS:RedstoneConnect are due to announce interims, so with the potential takeover saga that might be where most of the interest lies. Lots of potential surprises await though, as there's a heck of a lot happening for most of my holdings at the moment.
Worst performer should have done much better on positive results, but SBTX:SkinBioTherapeutics are still quite a way off revenue so that possibly caused the 13% slide this week . These are now down by 34% since that exciting day when I bought them just seconds after the IPO. Bet if I hadn't bought them that day they would have soared! Sweetbiotix will undoubtedly soar the day that launches.
CWR:Ceres Power Holdings had a good week last week, climbing 6%, but this week dropped 9% to wipe out those gains.
WRES:W Resources looked like they might have turned a corner, but it was far too much to hope for as over 250 million shares were issued in yet another placing just after announcing that debt financing would cover remaining costs. I don't trust this company as far as I can throw the tungsten that they are so far failing to produce.
RED:RedT Energy only climbed 4% this week after the last 2 weeks as Share of the Week, but that was enough to take them into profit for the first time in ages.
Good news for ARL:Atlantis Resources which climbed 10% after an article was posted in the Daily Mail. It still leaves them down by 44% though, so a long way to go yet.
IQE:IQE recovered from the recent blip with a rise of 13% in my ISA, but these are going to have double digit movements nearly every week as I'm measuring rises and falls based on % of my purchase price of 29.5p.
Share of the Week was MTFB:Motif Bio with a staggering 36% rise after announcing the success of their phase III trial for Iclaprim. I'm quite surprised it didn't climb even further, although that would result in profit taking and a subsequent drop so maybe it's not a bad thing. Now it's just a case of seeing whether this will be allowed to create value or be bought out by a big boy while it's still cheap.
Seems like a while since the weekly movement was so small it doesn't really register on the graph.
The ISA and share portfolios look like this
| Weekly Change | |||
| Cash | £39.59 | -£3.75 | |
| Portfolio cost | £44,426.84 | +£0 | |
| Portfolio sell value (bid price - commission) | £48,041.86 | (+8.1%) | -£388.85 |
| Potential profits | £8,665.80 | +£70.54 | |
| Yr 3 Dividends | £0 | +£0 | |
| Yr 3 Profit from sales | £585.38 | +£0 | |
| Yr 3 Average monthly cash profit | £256.56 | (6.9%) | -£34.10 |
| Total Dividends | £1,179.05 | +£0 | |
| Total Profit from sales | £7,297.85 | +£0 | |
| Average monthly cash profit | £320.75 | (8.7%) | -£3.01 |
| (Sold stocks profit + Dividends - Fees / Months) |
Cash dropped due to the monthly ISA fee, potential profits actually grew by £70 but the 3% drop in OPTI:Optibiotix sent that back into loss and contributed most to the drop.
Nothing alarming, just happy to be above the red line.
The SIPP looks like this after week 97
| Weekly Change | |||
| Cash | £44.63 | -£10.17 | |
| Portfolio cost | £25,218.51 | +£0 | |
| Portfolio sell value (bid price - commission) | £27,071.83 | (7.3%) | -£120.88 |
| Potential profits | £3,082.58 | -£244.06 | |
| Yr 2 Dividends | £328.84 | +£0 | |
| Yr 2 Profit from sales | £6,575.33 | +£0 | |
| Yr 2 Average monthly cash profit | £656.55 | (31.2%) | -£15.92 |
| Total Dividends | £708.15 | +£0 | |
| Total Profit from sales | £8,925.19 | +£0 | |
| Average monthly cash profit | £425.75 | (20.3%) | -£4.90 |
| (Sold stocks profit + Dividends - Fees / Months) |
Cash dropped due to monthly fees, profits dropped twice as much as the weekly fall in value thanks to OPTI:Optibiotix and helped by the ARL:Atlantis Resources and IQE:IQE losses improving. CAML:Central Asia Metals survived the dividend ex-date intact and even managed to finish the week 3% up.
Remarkably similar to the previous graph.
The trading account looks like this after week 63
| Weekly Change | |||
| Cash | £79.63 | +£0 | |
| Portfolio cost | £486.05 | +£0 | |
| Portfolio sell value (bid price - commission) | £366.13 | (-24.7%) | -£5.56 |
| Potential profits | £0 | +£0 | |
| Dividends | £1.15 | +£0 | |
| Profit from sales | -£22.85 | +£0 | |
| Average monthly cash profit | -£1.49 | (-3.7%) | +£0.03 |
| (Sold stocks profit + Dividends - Fees / Months) |
There seemed to be much more positive momentum behind REDS:RedstoneConnect following a possible takeover bid, but that fizzled out when they claimed the approach was lacking in any detail and so wasn't being entertained. There's still no imminent prospect of me getting rid of these and so the account continues to languish in tedium.
Shame the top part of the graph isn't more symmetrical else it might look quite pretty in a few weeks.
Not much news anticipated during next week. REDS:RedstoneConnect are due to announce interims, so with the potential takeover saga that might be where most of the interest lies. Lots of potential surprises await though, as there's a heck of a lot happening for most of my holdings at the moment.
Sunday 1 October 2017
Week 112 Review - Back in the right direction
Last week's losses were reversed this week largely thanks to a major recovery in the OPTI:Optibiotix share price. The combined portfolios were up by £2,477 at a total value of £76,172 and the buffer between cost and value grew to £5,865.
Worst performer of the week was CAML:Central Asia Metals, losing 11% after the shares returned from suspension as they dropped down to around the placing price. I think we may be stuck around these levels until the placing is out of the way, but the enhanced profits should make this company an even better investment for the future.
IQE:IQE had another bad week, but not as bad as it has been. My SIPP holding only dropped by 2% but is now losing £163, but my ISA holding dropped 7% compared to my original cost price, but is still up by £6,137 (314%).
Far more good news stories this week, with CWR:Ceres Power Holdings climbing 6% which makes them up 59% on purchase price. REDS:RedstoneConnect climbed 7% after news of another contract and rumours they will be bought out. Could I finally get my trading account working properly?
OPTI:Optibiotix climbed a wonderful 9% following the clearing of the overhang left by an ex-director selling 1.75 million shares. That's now back in profit in all accounts and making paper profit of £1,395.
MTFB:Motif Bio is rising steadily and climbed another 9% this week making it up by 15% overall. I'm now excited about the prospects for this one.
Share of the Week for the second week in a row was RED:RedT Energy, climbing another 12% and now only losing £25 (2%). Could this get back into profit next week? There's momentum building as news of more and more sales comes in.
That's better - another week like the last 2 would have seen the red line crossed, which is something I'd rather never happen again.
The ISA and share accounts look like this
Sell value up almost as much as I lost last week and most of it was vanishing OPTI:Optibiotix losses which explains why profits are only up by £510 along with the loss of a bit more of my IQE:IQE profit.
Much better.
The SIPP looks like this after week 96
Profits soared thanks to OPTI:Optibiotix but there were some losses like IQE:IQE and TRX:Tissue Regenix to knock off some of the shine. I'm getting quite worried about TRX:Tissue Regenix now, as they are down by 43% and nothing seems to be turning around the relentless fall.
Just like the other graphs - going back in the right direction
The trading account looks like this after week 62
At last there seems to be the chance of a turnaround. If I can get this up to £420 then I'll have my £500 back and I can think about using this account as it was meant to be used.
Nearly there!
Loads happening next week with final results from CWR:Ceres Power on Wednesday. They still won't be making a profit, but a summary of all the exciting work going on should help the share price continue upwards. News that trials of their fuel cell in a boiler reduced energy costs by £400 and carbon emissions by 2 tonnes a year were very exciting. In a few years the demand for power as everyone plugs in their electric car for the night will be massive, and distributed power generation could be the answer. A fuel cell in every boiler would be huge.
SBTX:SkinBiotherapeutics posts final results on Thursday. These are not likely to be great and may cause a decline in the share price, but all it takes is one nugget of future prospects and maybe the recent rise will continue, especially if OPTI:Optibiotix is now demonstrating the potential with this science. The feel good factor could spread.
CAML:Central Asia Metals is likely to have another bad week, as the ex-dividend date is Friday and will trigger a 6.5p drop. Al I can hope is that the price increases by that much over the week as people buy into the dividend.
The JLP:Jubilee Platinum bulletin board is awash with gossip about a potential deal that they think will be announced during the week. I'm a little more dubious and will believe it when I see it. There's no doubt that the momentum is improving in this one, although it ended the week lower than it started, so perception may have got ahead of reality.
My main hope for the week is that RED:RedT Energy can climb the 2% required to take it into profit. I only wish I had kept the faith and bought more when they were at rock bottom, but I was starting to believe they were never going to sell a unit. Now I'm back thinking this one could be enormous.
I'm rather looking forward to next week...
Worst performer of the week was CAML:Central Asia Metals, losing 11% after the shares returned from suspension as they dropped down to around the placing price. I think we may be stuck around these levels until the placing is out of the way, but the enhanced profits should make this company an even better investment for the future.
IQE:IQE had another bad week, but not as bad as it has been. My SIPP holding only dropped by 2% but is now losing £163, but my ISA holding dropped 7% compared to my original cost price, but is still up by £6,137 (314%).
Far more good news stories this week, with CWR:Ceres Power Holdings climbing 6% which makes them up 59% on purchase price. REDS:RedstoneConnect climbed 7% after news of another contract and rumours they will be bought out. Could I finally get my trading account working properly?
OPTI:Optibiotix climbed a wonderful 9% following the clearing of the overhang left by an ex-director selling 1.75 million shares. That's now back in profit in all accounts and making paper profit of £1,395.
MTFB:Motif Bio is rising steadily and climbed another 9% this week making it up by 15% overall. I'm now excited about the prospects for this one.
Share of the Week for the second week in a row was RED:RedT Energy, climbing another 12% and now only losing £25 (2%). Could this get back into profit next week? There's momentum building as news of more and more sales comes in.
That's better - another week like the last 2 would have seen the red line crossed, which is something I'd rather never happen again.
The ISA and share accounts look like this
| Weekly Change | |||
| Cash | £43.34 | +£0 | |
| Portfolio cost | £44,426.84 | +£0 | |
| Portfolio sell value (bid price - commission) | £48,430.71 | (+9%) | +£1,757.59 |
| Potential profits | £8,595.26 | +£510.31 | |
| Yr 3 Dividends | £0 | +£0 | |
| Yr 3 Profit from sales | £585.38 | +£0 | |
| Yr 3 Average monthly cash profit | £290.66 | (7.9%) | -£41.52 |
| Total Dividends | £1,179.05 | +£0 | |
| Total Profit from sales | £7,297.85 | +£0 | |
| Average monthly cash profit | £323.76 | (8.7%) | -£2.91 |
| (Sold stocks profit + Dividends - Fees / Months) |
Sell value up almost as much as I lost last week and most of it was vanishing OPTI:Optibiotix losses which explains why profits are only up by £510 along with the loss of a bit more of my IQE:IQE profit.
Much better.
The SIPP looks like this after week 96
| Weekly Change | |||
| Cash | £54.80 | +£0 | |
| Portfolio cost | £25,218.51 | +£0 | |
| Portfolio sell value (bid price - commission) | £27,192.71 | (7.8%) | +£689.22 |
| Potential profits | £3,326.64 | +£748.83 | |
| Yr 2 Dividends | £328.84 | +£0 | |
| Yr 2 Profit from sales | £6,575.33 | +£0 | |
| Yr 2 Average monthly cash profit | £672.47 | (32%) | -£15.64 |
| Total Dividends | £708.15 | +£0 | |
| Total Profit from sales | £8,925.19 | +£0 | |
| Average monthly cash profit | £430.65 | (20.5%) | -£4.53 |
| (Sold stocks profit + Dividends - Fees / Months) |
Profits soared thanks to OPTI:Optibiotix but there were some losses like IQE:IQE and TRX:Tissue Regenix to knock off some of the shine. I'm getting quite worried about TRX:Tissue Regenix now, as they are down by 43% and nothing seems to be turning around the relentless fall.
Just like the other graphs - going back in the right direction
The trading account looks like this after week 62
| Weekly Change | |||
| Cash | £79.63 | +£0 | |
| Portfolio cost | £486.05 | +£0 | |
| Portfolio sell value (bid price - commission) | £371.69 | (-23.5%) | +£30.58 |
| Potential profits | £0 | +£0 | |
| Dividends | £1.15 | +£0 | |
| Profit from sales | -£22.85 | +£0 | |
| Average monthly cash profit | -£1.52 | (-3.8%) | +£0.02 |
| (Sold stocks profit + Dividends - Fees / Months) |
At last there seems to be the chance of a turnaround. If I can get this up to £420 then I'll have my £500 back and I can think about using this account as it was meant to be used.
Nearly there!
Loads happening next week with final results from CWR:Ceres Power on Wednesday. They still won't be making a profit, but a summary of all the exciting work going on should help the share price continue upwards. News that trials of their fuel cell in a boiler reduced energy costs by £400 and carbon emissions by 2 tonnes a year were very exciting. In a few years the demand for power as everyone plugs in their electric car for the night will be massive, and distributed power generation could be the answer. A fuel cell in every boiler would be huge.
SBTX:SkinBiotherapeutics posts final results on Thursday. These are not likely to be great and may cause a decline in the share price, but all it takes is one nugget of future prospects and maybe the recent rise will continue, especially if OPTI:Optibiotix is now demonstrating the potential with this science. The feel good factor could spread.
CAML:Central Asia Metals is likely to have another bad week, as the ex-dividend date is Friday and will trigger a 6.5p drop. Al I can hope is that the price increases by that much over the week as people buy into the dividend.
The JLP:Jubilee Platinum bulletin board is awash with gossip about a potential deal that they think will be announced during the week. I'm a little more dubious and will believe it when I see it. There's no doubt that the momentum is improving in this one, although it ended the week lower than it started, so perception may have got ahead of reality.
My main hope for the week is that RED:RedT Energy can climb the 2% required to take it into profit. I only wish I had kept the faith and bought more when they were at rock bottom, but I was starting to believe they were never going to sell a unit. Now I'm back thinking this one could be enormous.
I'm rather looking forward to next week...
Subscribe to:
Posts (Atom)